Summary
Programmed cell death protein 1 (PD-1) and its primary ligand PD-L1 are integral components of a significant immune checkpoint pathway, widely recognized for its central role in cancer immunotherapy. However, emerging evidence highlights their broader involvement in both the central and peripheral nervous systems. In this study, we demonstrate that PD-L1/PD-1 signaling in astrocytes during mouse brain development regulates astrocyte maturation and morphogenesis via the MEK/ERK pathway by targeting the downstream effector cysteine and glycine rich protein 1 (CSRP1). This enhanced astrocyte morphological complexity results in increased end-foot coverage of blood vessels. Additionally, aberrant secretion of CSRP1 by astrocytes interacts with oligodendrocyte precursor cells (OPCs) membrane proteins annexin A1 (ANXA1) and annexin A2 (ANXA2), leading to the exclusion of migrating OPCs from blood vessels. This disruption in OPC migration and differentiation results in abnormal myelination and is associated with cognitive deficits in the mice. Our results provide critical insights into the function of PD-L1/PD-1 signaling in astrocyte-OPC interactions and underscore its relevance to glial cell development and pathogenesis in neurodevelopmental disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Data availability
Sequencing data have been deposited in the Gene Expression Omnibus website with accession number GSE272614. This paper does not report original code.
Code availability
Sequencing data have been deposited in the Gene Expression Omnibus website with accession number GSE272614. This paper does not report original code.
References
Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450–61.
Cillo AR, Cardello C, Shan F, Karapetyan L, Kunning S, Sander C, et al. Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8(+) T cells to promote antitumor immunity. Cell. 2024;187:4373–4388.e4315.
Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science. 2024;384:eadf1329.
Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48:434–52.
Hua Y, Vella G, Rambow F, Allen E, Antoranz Martinez A, Duhamel M, et al. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop. Cancer Cell. 2022;40:1600–1618.e1610.
Meng X, Liu X, Guo X, Jiang S, Chen T, Hu Z, et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 2018;564:130–5.
Sugiura D, Okazaki IM, Maeda TK, Maruhashi T, Shimizu K, Arakaki R, et al. PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity. Nat Immunol. 2022;23:399–410.
Portnow J, Wang D, Blanchard MS, Tran V, Alizadeh D, Starr R, et al. Systemic anti-PD-1 immunotherapy results in PD-1 blockade on T cells in the cerebrospinal fluid. JAMA Oncol. 2020;6:1947–51.
Su W, Saravia J, Risch I, Rankin S, Guy C, Chapman NM, et al. CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer’s disease pathology. Nat Immunol. 2023;24:1735–47.
Miyajima M, Zhang B, Sugiura Y, Sonomura K, Guerrini MM, Tsutsui Y, et al. Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior. Nat Immunol. 2017;18:1342–52.
Kamiya A, Hayama Y, Kato S, Shimomura A, Shimomura T, Irie K, et al. Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression. Nat Neurosci. 2019;22:1289–305.
Chen G, Kim YH, Li H, Luo H, Liu DL, Zhang ZJ, et al. PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1. Nat Neurosci. 2017;20:917–26.
Linnerbauer M, Beyer T, Nirschl L, Farrenkopf D, Lößlein L, Vandrey O, et al. PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation. Nat Commun. 2023;14:5555.
Zhao J, Bang S, Furutani K, McGinnis A, Jiang C, Roberts A, et al. PD-L1/PD-1 checkpoint pathway regulates hippocampal neuronal excitability and learning and memory behavior. Neuron. 2023;111:2709–2726.e2709.
Yang Y, Brown MC, Zhang G, Stevenson K, Mohme M, Kornahrens R, et al. Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS. Neuro Oncol. 2023;25:1631–43.
Rao G, Latha K, Ott M, Sabbagh A, Marisetty A, Ling X, et al. Anti-PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells. Clin Cancer Res. 2020;26:4699–712.
Tewari BP, Woo AM, Prim CE, Chaunsali L, Patel DC, Kimbrough IF, et al. Astrocytes require perineuronal nets to maintain synaptic homeostasis in mice. Nat Neurosci. 2024;27:1475–88.
Lee JH, Kim JY, Noh S, Lee H, Lee SY, Mun JY, et al. Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis. Nature. 2021;590:612–7.
Timper K, Del RÃo-MartÃn A, Cremer AL, Bremser S, Alber J, Giavalisco P, et al. GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function. Cell Metab. 2020;31:1189–1205.e1113.
Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci. 2019;20:667–85.
Stadelmann C, Timmler S, Barrantes-Freer A, Simons M. Myelin in the central nervous system: structure, function, and pathology. Physiol Rev. 2019;99:1381–431.
Skoulidis F, Araujo HA, Do MT, Qian Y, Sun X, Cobo AG, et al. CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature. 2024;635:462–471.
Moon S, Jung M, Go S, Hong J, Sohn HS, Kim C, et al. Engineered nanoparticles for enhanced antitumoral synergy between macrophages and T cells in the tumor microenvironment. Adv Mater. 2024;36:e2410340.
Ghisoni E, Morotti M, Sarivalasis A, Grimm AJ, Kandalaft L, Laniti DD, et al. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach. Nat Rev Clin Oncol. 2024;21:801–17.
Xiao WW, Chen G, Gao YH, Lin JZ, Wu XJ, Luo HL, et al. Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: a randomized clinical trial. Cancer Cell. 2024;42:1570–1581.e1574.
Healy LM, Stratton JA, Kuhlmann T, Antel J. The role of glial cells in multiple sclerosis disease progression. Nat Rev Neurol. 2022;18:237–48.
He D, Xu H, Zhang H, Tang R, Lan Y, Xing R, et al. Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function. Immunity. 2022;55:159–173.e159.
Clark IC, Gutiérrez-Vázquez C, Wheeler MA, Li Z, Rothhammer V, Linnerbauer M, et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science. 2021;372:eabf1230.
Weng Q, Wang J, Wang J, He D, Cheng Z, Zhang F, et al. Single-cell transcriptomics uncovers glial progenitor diversity and cell fate determinants during development and gliomagenesis. Cell Stem Cell. 2019;24:707–723.e708.
Allen NJ, Lyons DA. Glia as architects of central nervous system formation and function. Science. 2018;362:181–5.
Ren SY, Xia Y, Yu B, Lei QJ, Hou PF, Guo S, et al. Growth hormone promotes myelin repair after chronic hypoxia via triggering pericyte-dependent angiogenesis. Neuron. 2024;112:2177–2196.e2176.
Li J, Miramontes TG, Czopka T, Monk KR. Synaptic input and Ca(2+) activity in zebrafish oligodendrocyte precursor cells contribute to myelin sheath formation. Nat Neurosci. 2024;27:219–31.
Rojo D, Dal Cengio L, Badner A, Kim S, Sakai N, Greene J, et al. BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep. Neuron. 2023;111:3604–3618.e3611.
Tsai HH, Niu J, Munji R, Davalos D, Chang J, Zhang H, et al. Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science. 2016;351:379–84.
Zhao Y, Zhu W, Wan T, Zhang X, Li Y, Huang Z, et al. Vascular endothelium deploys caveolin-1 to regulate oligodendrogenesis after chronic cerebral ischemia in mice. Nat Commun. 2022;13:6813.
Niu J, Tsai HH, Hoi KK, Huang N, Yu G, Kim K, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. 2019;22:709–18.
Chavali M, Ulloa-Navas MJ, Pérez-Borredá P, Garcia-Verdugo JM, McQuillen PS, Huang EJ, et al. Wnt-dependent oligodendroglial-endothelial interactions regulate white matter vascularization and attenuate injury. Neuron. 2020;108:1130–1145.e1135.
Su Y, Wang X, Yang Y, Chen L, Xia W, Hoi KK, et al. Astrocyte endfoot formation controls the termination of oligodendrocyte precursor cell perivascular migration during development. Neuron. 2023;111:190–201.e198.
Lee HG, Rone JM, Li Z, Akl CF, Shin SW, Lee JH, et al. Disease-associated astrocyte epigenetic memory promotes CNS pathology. Nature. 2024;627:865–72.
de Ceglia R, Ledonne A, Litvin DG, Lind BL, Carriero G, Latagliata EC, et al. Specialized astrocytes mediate glutamatergic gliotransmission in the CNS. Nature. 2023;622:120–9.
Nabel CS, Gourgue F, Vander Heiden MG. Macrophages dig into the obesity paradox in cancer. Immunity. 2024;57:1731–3.
Shiraishi Y, Nomura S, Sugawara S, Horinouchi H, Yoneshima Y, Hayashi H, et al. Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial. Lancet Respir Med. 2024;12:877–87.
Pfau SJ, Langen UH, Fisher TM, Prakash I, Nagpurwala F, Lozoya RA, et al. Characteristics of blood-brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells. Nat Neurosci. 2024;27:1892–903.
Liu D, Liao P, Li H, Tong S, Wang B, Lu Y, et al. Regulation of blood-brain barrier integrity by Dmp1-expressing astrocytes through mitochondrial transfer. Sci Adv. 2024;10:eadk2913.
Wu X, Liu H, Hu Q, Wang J, Zhang S, Cui W, et al. Astrocyte-derived extracellular vesicular miR-143-3p dampens autophagic degradation of endothelial adhesion molecules and promotes neutrophil transendothelial migration after acute brain injury. Adv Sci. 2024;11:e2305339.
Cheng YT, Luna-Figueroa E, Woo J, Chen HC, Lee ZF, Harmanci AS, et al. Inhibitory input directs astrocyte morphogenesis through glial GABA(B)R. Nature. 2023;617:369–76.
Soto JS, Neupane C, Kaur M, Pandey V, Wohlschlegel JA, Khakh BS. Astrocyte Gi-GPCR signaling corrects compulsive-like grooming and anxiety-related behaviors in Sapap3 knockout mice. Neuron. 2024;112:3412–3423.e3416.
Xu SB, Li XR, Fan P, Li X, Hong Y, Han X, et al. Single-cell transcriptome landscape and cell fate decoding in human brain organoids after transplantation. Adv Sci. 2024;11:e2402287.
Wang M, Zhang L, Novak SW, Yu J, Gallina IS, Xu LL, et al. Morphological diversification and functional maturation of human astrocytes in glia-enriched cortical organoid transplanted in mouse brain. Nat Biotechnol. 2024;43:52–62.
Zhang W, Ren J, Ding L, Zheng S, Ma R, Zhang M, et al. Nanotherapeutic approaches of interleukin-3 to clear the α-synuclein pathology in mouse models of Parkinson’s disease. Adv Sci. 2024;11:e2405364.
Guo Q, Gobbo D, Zhao N, Zhang H, Awuku NO, Liu Q, et al. Adenosine triggers early astrocyte reactivity that provokes microglial responses and drives the pathogenesis of sepsis-associated encephalopathy in mice. Nat Commun. 2024;15:6340.
Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–63.
Sun Q, Peng S, Xu Q, Weikop P, Hussain R, Song W, et al. Enhancing glymphatic fluid transport by pan-adrenergic inhibition suppresses epileptogenesis in male mice. Nat Commun. 2024;15:9600.
Sterling JK, Rajesh A, Droho S, Gong J, Wang AL, Voigt AP, et al. Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease. J Clin Invest. 2024;134:e180904.
Vivi E, Di Benedetto B. Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders. Mol Psychiatry. 2024;29:2821–33.
Taylor KR, Monje M. Neuron-oligodendroglial interactions in health and malignant disease. Nat Rev Neurosci. 2023;24:733–46.
Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611:769–79.
Yang SM, Michel K, Jokhi V, Nedivi E, Arlotta P. Neuron class-specific responses govern adaptive myelin remodeling in the neocortex. Science. 2020;370:eabd2109.
Xin W, Chan JR. Myelin plasticity: sculpting circuits in learning and memory. Nat Rev Neurosci. 2020;21:682–94.
Yang H, You L, Wang Z, Yang L, Wang X, Wu W, et al. Bile duct ligation elevates 5-HT levels in cerebral cortex of rats partly due to impairment of brain UGT1A6 expression and activity via ammonia accumulation. Redox Biol. 2024;69:103019.
Li JP, Lin CW, Huang CC, Lu YT, Ho YT, Yang SF, et al. Lipocalin 2 reduces MET levels by inhibiting MEK/ERK signaling to inhibit nasopharyngeal carcinoma cell migration. Cancers. 2022;14:5707.
Lu KH, Yang JS, Hsieh YH, Chu HJ, Chou CH, Lu EW, et al. Lipocalin-2 inhibits osteosarcoma cell metastasis by suppressing MET expression via the MEK-ERK pathway. Cancers. 2021;13:3181.
Pegram LM, Liddle JC, Xiao Y, Hoh M, Rudolph J, Iverson DB, et al. Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. Proc Natl Acad Sci USA. 2019;116:15463–8.
Lu B, Zhu DY, Yin JH, Xu H, Zhang CQ, Ke QF, et al. Incorporation of cerium oxide in hollow mesoporous bioglass scaffolds for enhanced bone regeneration by activating the ERK signaling pathway. Biofabrication. 2019;11:025012.
Knierim E, Hirata H, Wolf NI, Morales-Gonzalez S, Schottmann G, Tanaka Y, et al. Mutations in subunits of the activating signal cointegrator 1 complex are associated with prenatal spinal muscular atrophy and congenital bone fractures. Am J Hum Genet. 2016;98:473–89.
Wimmer U, Wang Y, Georgiev O, Schaffner W. Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res. 2005;33:5715–27.
Yan P, Li Q, Wang L, Lu P, Suzuki K, Liu Z, et al. FOXO3-engineered human ESC-derived vascular cells promote vascular protection and regeneration. Cell Stem Cell. 2019;24:447–461.e448.
Miyasaka KY, Kida YS, Sato T, Minami M, Ogura T. Csrp1 regulates dynamic cell movements of the mesendoderm and cardiac mesoderm through interactions with dishevelled and diversin. Proc Natl Acad Sci USA. 2007;104:11274–9.
Clayton BLL, Barbar L, Sapar M, Kalpana K, Rao C, Migliori B, et al. Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis. Cell Stem Cell. 2024;31:1701–1713.e8.
O’Shea TM, Ao Y, Wang S, Ren Y, Cheng AL, Kawaguchi R, et al. Derivation and transcriptional reprogramming of border-forming wound repair astrocytes after spinal cord injury or stroke in mice. Nat Neurosci. 2024;27:1505–21.
Linnerbauer M, Lößlein L, Vandrey O, Peter A, Han Y, Tsaktanis T, et al. The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology. Nat Immunol. 2024;25:432–47.
Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91–110.
Weiss SA, Huang AY, Fung ME, Martinez D, Chen ACY, LaSalle TJ, et al. Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control. Nat Immunol. 2024;25:1871–83.
Sultan H, Takeuchi Y, Ward JP, Sharma N, Liu TT, Sukhov V, et al. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024;632:182–91.
Bader JE, Wolf MM, Lupica-Tondo GL, Madden MZ, Reinfeld BI, Arner EN, et al. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature. 2024;630:968–75.
Mauro D, Lin X, Pontarini E, Wehr P, Guggino G, Tang Y, et al. CD8(+) tissue-resident memory T cells are expanded in primary Sjögren’s disease and can be therapeutically targeted by CD103 blockade. Ann Rheum Dis. 2024;83:1345–57.
Qiu F, Jiang P, Zhang G, An J, Ruan K, Lyu X, et al. Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells. Nat Commun. 2024;15:4327.
Sui X, Ma J, Han W, Wang X, Fang Y, Li D, et al. The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients. Oncotarget. 2015;6:19393–404.
McNamara NB, Munro DAD, Bestard-Cuche N, Uyeda A, Bogie JFJ, Hoffmann A, et al. Microglia regulate central nervous system myelin growth and integrity. Nature. 2023;613:120–9.
Han X, Chen M, Wang F, Windrem M, Wang S, Shanz S, et al. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell. 2013;12:342–53.
Acknowledgements
We gratefully thank Bin Zhou (Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences) for providing PDGFRα-GFP mice. This work was supported by grants from the National Natural Science Foundation of China (32450088, 92368203, 32230040, 92468302), the National Key R&D Program of China (2024YFA1802600, 2024YFA1802202, 2021YFA1101402, 2024YFA1107500, and 2023YFA1801500), the Key Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Sciences (2024KF04), and the Initiative Scientific Research Program, Institute of Zoology, Chinese Academy of Sciences (2024IOZ0104 and 2023IOZ0304).
Author information
Authors and Affiliations
Contributions
YW and JJ designed the study. YW conducted the experiments and drafted the manuscript. MZ performed the data analysis with contributions from all authors. TZ carried out mouse genotype identification. SZ provided insights on data analysis. FJ advised on experimentation and manuscript writing. JQ was responsible for animal care. HL provided some advice about experiences. JJ supervised the project and secured funding.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Y., Zhang, M., Zhang, T. et al. PD-L1/PD-1 checkpoint pathway regulates astrocyte morphogenesis and myelination during brain development. Mol Psychiatry 30, 3895–3911 (2025). https://doi.org/10.1038/s41380-025-02969-3
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41380-025-02969-3